MedTrace Logo

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

NCT00003262 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-09-20

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of two combination chemotherapy regimens in treating patients with Hodgkin's disease and HIV infection.

Conditions

Interventions

BIOLOGICAL

bleomycin sulfate

BIOLOGICAL

filgrastim

DRUG

Stanford V regimen

DRUG

doxorubicin hydrochloride

DRUG

epirubicin hydrochloride

DRUG

etoposide

DRUG

mechlorethamine hydrochloride

DRUG

prednisone

DRUG

vinblastine sulfate

DRUG

vincristine sulfate

Sponsors & Collaborators

  • Centro di Riferimento Oncologico - Aviano

    lead OTHER

Principal Investigators

  • Umberto Tirelli, MD · Centro di Riferimento Oncologico - Aviano

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003262 on ClinicalTrials.gov